But actually, its hard for me to think that these failed biotechs can go much lower
I'm currently watching about 30 cashfat-biobusts with a pps at, near, or below cash. Trading a few but only smallish trading as I believe several of them will trend much lower as this year 2021 comes to an end.
Couple chart examples with most every shareholder (in the past year) able to take a loss - RFL & ADVM: